Table 3. Demographics of participants with ICSD2-derived insomnia in the TuCASA study.
| No insomnia | Intermittent Insomnia | Persistent insomnia | p | |
|---|---|---|---|---|
| Gender | 0.4 | |||
| Male | 65 (48%) | 28 (54%) | 5 (71%) | |
| Female | 70 (52%) | 24 (46%) | 2 (29%) | |
| Ethnicity | 0.2 | |||
| Caucasian | 95 (70%) | 30 (58%) | 6 (86%) | |
| Hispanic | 40 (30%) | 22 (42%) | 1 (14%) | |
| Age‡ | 15 (±1.7) | 15 (±1.7) | 13 (±1.0) | 0.001 |
| Parent education level | 0.3 | |||
| < 4 years of college | 66 (49%) | 31 (60%) | 5 (71%) | |
| ≥ 4 years of college | 69 (51%) | 21 (40%) | 2 (29%) | |
| Family income | 0.4 | |||
| <$40,000 | 45 (33%) | 19 (37%) | 4 (57%) | |
| ≥$40,000 | 90 (67%) | 33 (63%) | 3 (43%) | |
| Current use of psychiatric medication | 0.007 | |||
| No | 128 (95%) | 47 (90%) | 4 (57%) | |
| Yes | 7 (5%) | 5 (10%) | 3 (43%) | |
| Obstructive sleep apnea | 0.3 | |||
| Absent | 133 (99%) | 50 (96%) | 7 (100%) | |
| Present | 2 (1%) | 2 (4%) | 0 (0%) | |
| New Medication | 0.03 | |||
| No | 117 (87%) | 39 (75%) | 4 (57%) | |
| Yes | 18 (13%) | 13 (25%) | 3 (43%) | |
| New Psychiatric Medication | 0.01 | |||
| No | 128 (95%) | 48 (92%) | 4 (57%) | |
| Yes | 7 (5%) | 4 (8%) | 3 (43%) | |
| New medical condition | 0.15 | |||
| No | 117 (87%) | 39 (58%) | 6 (86%) | |
| Yes | 18 (13%) | 13 (42%) | 1 (14%) |
The use of psychiatric medication, starting a new medication, starting a new psychiatric medication and age were significantly different between groups. All data is from phase 3, except socioeconomic data, which was collected at phase 2.
‡Age is reported as mean ± standard deviation.